What the Research Says (The Conflict)

The Lipid Hypothesis — The Case Against Cholesterol

The Framingham Heart Study, launched in 1948 and still running today, is the most-cited evidence that higher LDL cholesterol correlates with increased cardiovascular risk.

Decades of statin trials followed, showing that lowering LDL reduces cardiac events in high-risk populations. Mainstream medicine drew a clean line: lower LDL = lower risk. Full stop.

The Other Half of the Story

Every cell in your body needs cholesterol. It builds cell membranes, produces vitamin D, synthesizes every major steroid hormone — testosterone, estrogen, cortisol — and repairs cellular damage.

Zero cholesterol means zero life.

Your liver manufactures approximately 75-80% of your body's cholesterol precisely because the body cannot function without it. When you eat less cholesterol, the liver makes more. The body treats it as a critical raw material, not a toxin.

Further complicating the "lower is better" narrative: in adults over 60, lower total cholesterol has been associated in several observational studies with higher all-cause mortality — the opposite of what the lipid hypothesis predicts. However, this is likely influenced by reverse causation: chronic disease, frailty, and hidden malignancy can drive cholesterol down while also increasing mortality risk. Observational U-curves do not prove that low cholesterol itself is harmful.

The ALLHAT-LLT trial found hazard ratios for all-cause mortality in the pravastatin group of 1.18 for adults 65+ and 1.34 for adults 75+ — meaning older adults on statins had directionally worse outcomes. But these results did not reach statistical significance (confidence intervals crossed 1.0), so they constitute a null finding, not evidence of harm.

Meanwhile, Mendelian randomization studies — which are not subject to reverse causation — show that genetic variants producing lifelong lower LDL consistently reduce cardiovascular events without a signal of increased mortality in older age. That is a strong counterweight to any claim that "low LDL is dangerous."

Why Both Can Be True

The missing variable is context.

Cholesterol does not spontaneously attack arteries. The actual mechanism involves three steps:

Research published in Frontiers in Cardiovascular Medicine (2022) confirms that it is oxidized LDL — not standard LDL — that triggers endothelial dysfunction, foam cell formation, and plaque instability. A 2025 PMC study found that LDL oxidation levels inside plaques are nearly 70 times higher than in circulating plasma from the same patient.

The research asking "is cholesterol associated with disease?" and the research asking "is cholesterol essential for life?" are studying two completely different phenomena. They are not contradicting each other. They are not even in the same conversation.

The Real Diagnosis

What makes LDL dangerous is not its presence—it is whether it has been oxidized and whether the arterial wall is already compromised.

That shifts the real questions to:

• Is metabolic health intact? Insulin resistance dramatically increases LDL oxidation.
• Is systemic inflammation elevated? CRP, IL-6, and homocysteine are stronger predictors of cardiovascular risk than raw LDL number.
• What is the LDL particle size? Small, dense LDL oxidizes far more easily than large, buoyant LDL — and particle concentration (LDL-P) often predicts risk better than LDL-C alone.
• Is oxidative stress high? From smoking, processed food, sleep deprivation, or chronic stress.

The Framingham study itself, in a finding almost never cited, found no discernible relationship between reported dietary intake and serum cholesterol levels. The lead investigator clarified this was attributable to limitations of self-reported dietary data—not because the biology is settled. The distinction matters: the data was inconclusive, not exonerating.

The Practical Implication

Before focusing on driving LDL lower, the more productive engineering question is:

That answer involves metabolic health, insulin sensitivity, oxidative stress, and chronic inflammation — topics the original cholesterol hypothesis barely addressed.

An LDL number without context is like a body temperature reading without knowing whether the patient is exercising or fighting an infection.

Practical starting point: if your fasting insulin is elevated, your small dense LDL fraction is high, your CRP is above 1.0 mg/L or your HbA1c is trending up — address those conditions first. They represent the environment in which cholesterol becomes dangerous. LDL quantity still matters — but quantity without context is an incomplete picture.

Address the fire risk. Not just the lumber count.